| abstract |
The present invention is related to Ruthenium derived antitumoral compounds with high antimetastatic activity and with low toxicity for the host. It is described the use of inorganic Ruthenium complexes in the therapy of solid tumors, in particular of those tumors characterized by high metastatizing ability. Pharmaceutical compositions containing Ruthenium complexes in formulations suitable for the administration and a kit for the preparation of such complexes at the moment of use or immediately before use, are moreover described. |